Health 4.0 and the End of Zero-Sum Healthcare

The Money Paper in The Trajectory Engineering Papers, No. IV. Companion to Doctor AI: Reimagining Healthcare, Rebuilding Trust, Delivering Health 4.0 (Blackstone Press; 7 April 2026). American healthcare is approaching a structural debt cliff. National health expenditure reached $5.3 trillion in 2024, or 18.0 percent of GDP, and the Centers for Medicare and Medicaid Services (CMS) projects health spending will reach 20.3 percent of GDP by 2033. The Medicare Hospital Insurance Trust Fund is projected to be depleted in 2033. Employer-sponsored insurance covers approximately 154 million people under age 65; in 2025 the average family premium reached $26,993, with workers contributing $6,850. The status quo has no credible aggregate-bending mechanism. It shifts cost among households, employers, public programs, providers, and local governments while the total burden continues to rise. This paper specifies a Health 4.0 financing and governance architecture for Region Zero: the United States. It is the Money Paper in The Trajectory Engineering Papers. The claim is not that a single payer, voucher, price-control instrument, or digital tool can solve American healthcare. The claim is that cost, outcome, and trust must be redesigned together. The proposed architecture is organized around a Health Commons Endowment, a visible Health Trajectory Benefit attached to the Health Principal, a five-pillar economic mechanism, a staged migration path, public-purpose governance, and a legal bridge that can operate before any constitutional amendment is ratified. The model is separated into two accounting frames. The conservative public-scoring frame includes NHE-facing and financing flows: administrative and process waste recovery, pharmaceutical price alignment, clinical-debt disposition with adherence uplift, and endowment draw net of bridge-bond service. The comprehensive Health 4.0 system-value frame adds productivity recapture as a separate national-output dividend. Productivity is not booked as medical-cost savings. The architecture is refuted if the cost curve, outcome curve, and trust curve fail to cross their status-quo counterfactuals within stated, dated falsification gates. This paper therefore offers a falsifiable specification and capital-mobilization thesis, not a settled actuarial estimate. v2.0, with the executable model supplement (h4_model.py + parameter table + correlated-downside Monte Carlo + OACT crosswalk) and the four additional figures listed in Appendix C, is planned for mid-2026.